Innovations in Diabetes Care for a Better "New Normal" Beyond COVID-19.
Level V
Where this comes from
- Record sourced from PubMed, PMID 33205818.
- Also identified by DOI 10.1210/clinem/dgaa704 and PMC identifier 7665547.
- Licence recorded as CC BY.
- The licence permits redistribution, so the abstract is shown in full and the full text is available from the publisher.
Abstract
The coronavirus disease pandemic has created opportunities for innovation in diabetes care that were not possible before. From the lens of this "new normal" state, we have an opportunity to rapidly implement, test, and iterate models of diabetes care to achieve the quadruple aim of improving medical outcomes, patient experience, provider satisfaction, and reducing costs. In this perspective, we discuss several innovative diabetes models of care which promote collaborative care models and improve access to high-quality specialty diabetes care. We discuss ongoing threats to diabetes care innovation, and offer practical solutions to foster evolution and sustain current strides made during the pandemic.
Medical subject headings
- COVID-19
- Diabetes Mellitus
- SARS-CoV-2